Jean Jacques Bienaime - 20 May 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
20 May 2024
Net transactions value
-$92,614
Form type
4
Filing time
21 May 2024, 16:09:39 UTC
Previous filing
13 May 2024
Next filing
22 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Tax liability $92,614 -1,202 -0.25% $77.05 473,792 20 May 2024 Direct
holding BMRN Common Stock 247,333 20 May 2024 Shares held by Jean-Jacques Bienaime Family Trust
holding BMRN Common Stock 100 20 May 2024 Shares held as UTMA custodian for child 1
holding BMRN Common Stock 100 20 May 2024 Shares held as UTMA custodian for child 2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jean Jacques Bienaime is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.